IFNG and bacterial infectious disease with sepsis: Combination therapy of nivolumab and interferon gamma (IFN-γ) has been reported to reverse immune suppression during fungal and bacterial sepsis by boosting lymphocyte count, monocyte activation, and CD8+ T cells [65,70].